What is Brio Systems?
Founded in 2017 and based in Boston, Massachusetts, Brio Systems offers a complete COVID-19 testing system designed to help employers maintain safe work environments and ensure business continuity. The platform integrates access to lab-backed PCR and antibody testing, provides end-to-end logistics support for employers navigating the testing process, includes comprehensive medical oversight, and facilitates secure digital communication of results, typically within three days of sample collection. This holistic approach positions Brio Systems as a key player in the corporate health and safety sector.
How much funding has Brio Systems raised?
Brio Systems has raised a total of $1.9M across 1 funding round:
Angel/Seed
$1.9M
Angel/Seed (2020): $1.9M with participation from Castor Ventures, Nimble Ventures, One Way Ventures, John Capodilupo, and Techstar Ventures
Key Investors in Brio Systems
Castor Ventures
Castor Ventures is a venture capital firm that likely focuses on early-stage investments, potentially in technology or growth-oriented companies.
Nimble Ventures
Nimble Ventures appears to be a venture builder or accelerator that assists innovators in bringing products to market, from validation and development through to funding and distribution.
One Way Ventures
One Way Ventures is a venture capital firm, likely specializing in investments within the technology sector.
What's next for Brio Systems?
The recent major strategic investment signals a strong vote of confidence in Brio Systems' operational model and its capacity to scale. This capital infusion is likely to fuel further expansion of its testing infrastructure, enhance its digital platform for results management, and potentially broaden its service offerings to address evolving workplace health needs. The company is well-positioned to capitalize on the ongoing demand for reliable and efficient employee health monitoring solutions, reinforcing its market presence.
See full Brio Systems company page
